Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 5 | 2024 | 1257 | 0.920 |
Why?
|
Blood Vessel Prosthesis | 6 | 2011 | 956 | 0.800 |
Why?
|
Heart Failure | 9 | 2024 | 11837 | 0.760 |
Why?
|
Activin Receptors, Type II | 1 | 2019 | 122 | 0.600 |
Why?
|
Stroke Volume | 6 | 2022 | 5595 | 0.590 |
Why?
|
Tissue Engineering | 7 | 2010 | 1857 | 0.570 |
Why?
|
Aging | 5 | 2020 | 8723 | 0.540 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 899 | 0.520 |
Why?
|
Myocardium | 6 | 2024 | 4766 | 0.510 |
Why?
|
Cardiovascular Agents | 1 | 2022 | 848 | 0.510 |
Why?
|
Cardiomyopathies | 2 | 2024 | 2068 | 0.470 |
Why?
|
Cardiomegaly | 2 | 2018 | 590 | 0.450 |
Why?
|
Tissue Scaffolds | 5 | 2011 | 934 | 0.440 |
Why?
|
Bone Marrow Cells | 4 | 2010 | 2411 | 0.420 |
Why?
|
Exercise | 3 | 2020 | 5939 | 0.420 |
Why?
|
Heart | 4 | 2020 | 4419 | 0.360 |
Why?
|
Heart Diseases | 1 | 2024 | 2818 | 0.360 |
Why?
|
Exercise Tolerance | 1 | 2016 | 841 | 0.350 |
Why?
|
Physical Conditioning, Animal | 2 | 2022 | 365 | 0.310 |
Why?
|
Blood Vessels | 2 | 2011 | 1113 | 0.290 |
Why?
|
Peripartum Period | 2 | 2024 | 138 | 0.260 |
Why?
|
Coated Materials, Biocompatible | 1 | 2007 | 314 | 0.250 |
Why?
|
Ventricular Remodeling | 2 | 2024 | 1276 | 0.230 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2024 | 481 | 0.210 |
Why?
|
Bioprosthesis | 2 | 2008 | 592 | 0.210 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2010 | 1456 | 0.210 |
Why?
|
Boidae | 1 | 2022 | 14 | 0.200 |
Why?
|
Polyglycolic Acid | 3 | 2008 | 406 | 0.200 |
Why?
|
Stromal Cells | 1 | 2007 | 1332 | 0.190 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1674 | 0.190 |
Why?
|
Polyesters | 3 | 2007 | 373 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2024 | 939 | 0.180 |
Why?
|
Puerperal Disorders | 1 | 2023 | 304 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 559 | 0.180 |
Why?
|
Methacrylates | 1 | 2020 | 109 | 0.170 |
Why?
|
Animals | 21 | 2024 | 168800 | 0.170 |
Why?
|
Signal Transduction | 3 | 2020 | 23605 | 0.170 |
Why?
|
Follistatin-Related Proteins | 1 | 2019 | 48 | 0.160 |
Why?
|
Tissue Adhesives | 1 | 2020 | 177 | 0.150 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 132 | 0.150 |
Why?
|
Gelatin | 1 | 2020 | 227 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 530 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1601 | 0.150 |
Why?
|
Activins | 1 | 2019 | 210 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 833 | 0.140 |
Why?
|
Cells, Cultured | 7 | 2024 | 18967 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1077 | 0.140 |
Why?
|
Mice, SCID | 4 | 2010 | 2626 | 0.140 |
Why?
|
Endothelial Cells | 2 | 2024 | 3586 | 0.140 |
Why?
|
Enalapril | 1 | 2018 | 317 | 0.130 |
Why?
|
Systole | 1 | 2019 | 935 | 0.130 |
Why?
|
Ureteral Obstruction | 1 | 2018 | 293 | 0.130 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2017 | 145 | 0.130 |
Why?
|
Sheep | 3 | 2008 | 1445 | 0.130 |
Why?
|
Surgical Mesh | 3 | 2008 | 315 | 0.130 |
Why?
|
Mice | 12 | 2024 | 81839 | 0.130 |
Why?
|
Pressure | 1 | 2019 | 1171 | 0.120 |
Why?
|
Diastole | 1 | 2018 | 785 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1102 | 0.120 |
Why?
|
Biocompatible Materials | 3 | 2008 | 1685 | 0.120 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2016 | 242 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2009 | 701 | 0.120 |
Why?
|
Placenta | 1 | 2024 | 1726 | 0.120 |
Why?
|
Mitochondria, Heart | 1 | 2016 | 228 | 0.120 |
Why?
|
Interferon Type I | 1 | 2017 | 568 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22341 | 0.110 |
Why?
|
Models, Animal | 4 | 2022 | 2120 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1318 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18321 | 0.100 |
Why?
|
Pregnancy | 5 | 2024 | 30233 | 0.100 |
Why?
|
Ligands | 1 | 2019 | 3274 | 0.100 |
Why?
|
Calcium Signaling | 1 | 2016 | 734 | 0.090 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2390 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2011 | 86 | 0.090 |
Why?
|
Phenotype | 2 | 2020 | 16716 | 0.090 |
Why?
|
Heart Ventricles | 2 | 2019 | 3833 | 0.080 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.080 |
Why?
|
Humans | 22 | 2024 | 766117 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9527 | 0.080 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2010 | 168 | 0.080 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2010 | 938 | 0.070 |
Why?
|
Hydroxyproline | 1 | 2007 | 107 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2020 | 11509 | 0.070 |
Why?
|
Dioxanes | 1 | 2007 | 36 | 0.070 |
Why?
|
Hypertension | 3 | 2023 | 8616 | 0.070 |
Why?
|
Centrifugation | 1 | 2007 | 121 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15882 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 602 | 0.070 |
Why?
|
Porosity | 1 | 2007 | 347 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3283 | 0.070 |
Why?
|
Postpartum Period | 2 | 2024 | 1195 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2010 | 374 | 0.070 |
Why?
|
Cell Culture Techniques | 2 | 2010 | 1651 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11035 | 0.060 |
Why?
|
Monocytes | 2 | 2018 | 2591 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12130 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2306 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2024 | 113 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
Age Factors | 2 | 2021 | 18386 | 0.050 |
Why?
|
Macrophages | 1 | 2018 | 5776 | 0.050 |
Why?
|
Rats | 1 | 2019 | 23717 | 0.050 |
Why?
|
Lactic Acid | 1 | 2007 | 1137 | 0.050 |
Why?
|
Thymidine | 1 | 2022 | 294 | 0.050 |
Why?
|
Fibrosis | 2 | 2020 | 2073 | 0.050 |
Why?
|
Female | 12 | 2024 | 396233 | 0.050 |
Why?
|
Blood Pressure | 3 | 2023 | 8532 | 0.050 |
Why?
|
Calcineurin | 1 | 2022 | 233 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2010 | 11642 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 263 | 0.040 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2022 | 239 | 0.040 |
Why?
|
Polymers | 1 | 2007 | 1622 | 0.040 |
Why?
|
Aorta | 1 | 2008 | 2040 | 0.040 |
Why?
|
Male | 9 | 2024 | 363935 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 346 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2007 | 1727 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 590 | 0.040 |
Why?
|
Dependovirus | 1 | 2024 | 721 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1282 | 0.040 |
Why?
|
Drug Compounding | 1 | 2020 | 236 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1038 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 509 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15647 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2024 | 1043 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1370 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59515 | 0.030 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 113 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7426 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5300 | 0.030 |
Why?
|
Inflammation | 2 | 2017 | 10860 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2024 | 3400 | 0.030 |
Why?
|
Hydrogels | 1 | 2020 | 729 | 0.030 |
Why?
|
Aged | 4 | 2021 | 171219 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2667 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223139 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7193 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1805 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2260 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3094 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1181 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14456 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2007 | 10433 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1513 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 250 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 1996 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 223083 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 65219 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3715 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4133 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3606 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74857 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2018 | 2060 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9508 | 0.020 |
Why?
|
Tachycardia | 1 | 2010 | 598 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6545 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4162 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3930 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3338 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 532 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12529 | 0.020 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 463 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14747 | 0.020 |
Why?
|
Vascular Patency | 1 | 2008 | 914 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12803 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2011 | 1852 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3787 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2729 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2009 | 1494 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6820 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2008 | 2111 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5747 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10811 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36427 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9540 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54812 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 4423 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8724 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12976 | 0.010 |
Why?
|
United States | 1 | 2021 | 72920 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 59868 | 0.000 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_